ABA therapy centers with clean billing records, diversified payor contracts, and retained BCBA staff are transacting at 3.5x–6x EBITDA. Here's exactly how buyers determine value — and how to maximize yours.
Find Autism Therapy Center Businesses For SaleAutism therapy centers are most commonly valued using a multiple of Seller's Discretionary Earnings (SDE) for owner-operated single-site practices or EBITDA for multi-site and clinician-managed operations. Valuation multiples are heavily influenced by BCBA staffing depth, payor mix quality, billing compliance history, and the degree to which the business can operate independently of the founding owner. Given persistent demand, strong insurance mandate tailwinds across all 50 states, and active PE consolidation in the ABA space, well-prepared centers are commanding premiums at the higher end of the 3.5x–6x EBITDA range.
3.5×
Low EBITDA Multiple
4.75×
Mid EBITDA Multiple
6×
High EBITDA Multiple
Single-site ABA centers with owner-dependent clinical operations, Medicaid-concentrated payor mix, or fewer than two independently credentialed BCBAs typically trade at 3.5x–4x EBITDA. Centers with two or more BCBAs, diversified Medicaid and commercial payor contracts, documented clinical outcomes, and scalable EMR-based systems trade at 4.5x–5.5x. PE platform add-on acquisitions in high-demand markets or centers with long waitlists and strong referral networks can exceed 6x EBITDA when competitive bidding is involved.
$2,200,000
Revenue
$440,000
EBITDA
5x
Multiple
$2,200,000
Price
SBA 7(a) loan covering $1,980,000 (90% of purchase price) with a 10% buyer equity injection of $220,000. Seller carries a $150,000 subordinated seller note at 6% over 5 years, structured to satisfy SBA standby requirements. No earnout; seller agrees to a 9-month transition at 20 hours per week to support BCBA credentialing continuity and payor re-enrollment.
EBITDA Multiple
The dominant valuation method for ABA therapy centers with revenue above $1.5M and a clinical director or lead BCBA who is not the selling owner. A normalized EBITDA — adjusted for owner compensation, one-time expenses, and any non-recurring revenue — is multiplied by a market-based factor reflecting clinical quality, payor mix, and staff retention. Most institutional buyers and PE platforms use this method exclusively.
Best for: Multi-site operators, clinician-managed centers, and any practice being acquired by a PE-backed behavioral health platform
Seller's Discretionary Earnings (SDE)
Used for owner-operated ABA practices where the founding BCBA draws a below-market salary and is central to daily operations. SDE adds back the owner's compensation, personal benefits, and discretionary expenses to net income, providing a cleaner picture of true cash flow for a working owner-buyer. SDE multiples for autism centers typically range from 2.5x–4x depending on transferability risk.
Best for: Solo BCBA-owned practices, husband-and-wife clinical operators, and centers being acquired via SBA 7(a) financing by an individual buyer
Revenue Multiple
A less precise but commonly referenced benchmark used during early-stage deal screening. ABA therapy centers generally trade at 0.6x–1.2x trailing twelve-month revenue, with the range driven by EBITDA margin quality. A center producing 20%+ EBITDA margins will trade closer to 1x–1.2x revenue, while a lower-margin or turnaround-stage center may trade at 0.6x–0.8x revenue. Revenue multiples are rarely used as the sole valuation basis in a formal transaction.
Best for: Initial deal screening, broker opinion of value, and back-of-envelope pricing conversations before full financial diligence
BCBA Staffing Depth and Retention
Buyers assign significant premium to centers with two or more BCBAs who hold independent payor credentialing and are under multi-year employment agreements. A center where clinical operations do not depend on the selling owner is far more transferable — and commands multiples 0.5x–1x higher than owner-dependent practices. BCBA non-solicitation agreements and documented supervision ratios further reduce post-close staffing risk.
Diversified Payor Mix
Centers with a balanced blend of Medicaid and commercial insurance contracts command higher multiples than those concentrated in a single payor. Commercial reimbursement rates are typically 15–30% higher than Medicaid, and payor diversification insulates the business from state budget-driven rate compression. Buyers specifically evaluate the percentage of revenue from the top one or two payors and discount aggressively when a single payor exceeds 60% of billings.
Clean Billing and Compliance History
Three years of reconciled financial statements, low claim denial rates, no outstanding Medicaid overpayment demands, and a clean billing audit history are among the highest-value signals a seller can present. Billing irregularities create material indemnification risk that buyers price into deal structure — often via escrow holdbacks or reduced purchase price. A clean revenue cycle record can meaningfully accelerate deal closing and reduce escrow requirements.
Documented Clinical Outcomes and EMR Consistency
Buyers — particularly PE platforms — place increasing weight on documented client progress data, standardized treatment plan formats, and consistent clinical records across the caseload. Centers using established EMR platforms like CentralReach or Catalyst with complete authorization tracking and session documentation demonstrate operational maturity that justifies premium pricing and reduces diligence friction.
Long Waitlist and Referral Network Strength
A meaningful waitlist — typically 20 or more families awaiting intake — signals unmet demand and pricing power, and directly supports acquirer assumptions about growth capacity post-close. Strong referral relationships with pediatric neurologists, school districts, and early intervention programs are treated as durable competitive moats that protect revenue without ongoing marketing spend.
Authorization Hours and Client Tenure
Buyers model revenue based on authorized weekly therapy hours per client multiplied by reimbursement rates. Centers with high average authorization hours (15–30 hours per week per client) and long average client tenure (2–4 years) generate more predictable recurring revenue and higher lifetime value per client. A client census report showing stable or growing average authorization hours is a key diligence deliverable that supports valuation.
Owner Acts as Sole Clinical Supervisor
When the selling BCBA is the only credentialed supervisor in the practice, buyers face an immediate post-close risk: the center cannot legally operate ABA services without that individual. This single factor can disqualify a practice from institutional acquisition entirely or force a severe valuation discount and extended transition requirement. Sellers must credential at least one additional BCBA independently with all active payors before going to market.
Medicaid Concentration Above 70% of Revenue
Practices deriving more than 70% of revenue from Medicaid are highly exposed to state reimbursement rate changes, audit risk, and enrollment disruptions. Buyers in competitive processes will apply a discount or demand seller note protection against rate compression. Diversifying toward commercial payors — even modestly — before a sale materially improves valuation and deal structure terms.
Billing Irregularities or Prior Audit Activity
Any history of Medicaid audits, overpayment recoupment demands, billing corrections, or unresolved claim disputes creates significant liability that buyers will price into the transaction. Even resolved billing issues require extensive documentation. Active or unresolved compliance matters will either kill a deal outright or result in a substantial escrow holdback that delays seller liquidity.
High BCBA Turnover Without Pipeline
BCBA turnover rates above 30% annually signal cultural or compensation problems that buyers model as ongoing drag on revenue and margin. Without a documented recruiting pipeline — university partnerships, supervision stipend programs, or RBT-to-BCBA advancement pathways — buyers assume elevated replacement costs that compress their return assumptions and reduce the multiple they are willing to pay.
Underdocumented Treatment Plans and Clinical Records
Inconsistent or incomplete clinical documentation across the active caseload creates both regulatory liability and diligence delays. Medicaid and commercial payors can demand recoupment for sessions lacking compliant documentation. Buyers conducting clinical diligence will flag incomplete records as an indemnification risk, often resulting in escrow holdbacks or price reductions proportional to the estimated exposure.
No EMR System or Fragmented Data
Centers managing scheduling, billing, and clinical documentation through spreadsheets or disconnected systems present significant operational risk to acquirers. The absence of a standardized EMR platform signals that client census data, authorization tracking, and billing records cannot be efficiently validated during diligence — slowing deal timelines and reducing buyer confidence in reported revenue figures.
Find Autism Therapy Center Businesses For Sale
Signal-scored targets with seller motivation, multiples, and outreach — free to join.
Most institutional buyers and SBA-financed individual buyers target ABA therapy centers with EBITDA margins between 15% and 25%. Centers below 12% margin are typically viewed as turnaround opportunities and priced accordingly, while centers consistently producing 20%+ margins with strong BCBA retention attract competitive bidding and premium multiples. Owner compensation normalization is critical — many owner-operated centers show thin reported margins that normalize significantly once the owner's below-market salary is adjusted to a market-rate clinical director equivalent.
Medicaid contracts provide reliable volume and are a baseline expectation for most buyers, but heavy Medicaid concentration — above 65–70% of revenue — introduces reimbursement rate risk that buyers discount into valuation. States can and do reduce ABA reimbursement rates, sometimes with little notice, and Medicaid billing carries higher audit risk than commercial insurance. Centers with a mix of Medicaid and commercial payor revenue, particularly in states with strong autism insurance mandates requiring commercial coverage, consistently command higher multiples and cleaner deal structures than Medicaid-only operators.
It is very difficult to sell at full market value if you are the only credentialed BCBA in the practice. Buyers — particularly PE platforms and SBA-financed buyers — require that the business can operate clinically without the seller after the transition period ends. If you are the sole BCBA, the practice is clinically dependent on your license and payor credentialing, which means any buyer faces immediate disruption risk at close. The solution is to hire and credential at least one additional BCBA — ideally two — and enroll them with all active payors before going to market. This step alone can increase your valuation by 0.5x–1.5x EBITDA.
The typical exit timeline for an ABA therapy center is 12–18 months from the decision to sell to closing. This includes 3–6 months of pre-market preparation (cleaning financials, credentialing staff, resolving billing issues), 2–4 months of active marketing and buyer qualification, 60–90 days of formal diligence and deal negotiation, and 30–60 days for SBA loan processing or PE platform approval and closing. State licensure transfer and Medicaid re-enrollment can add additional time post-close, which is why experienced buyers build transition support agreements into deal structure.
SDE (Seller's Discretionary Earnings) adds back the owner's full compensation — salary, benefits, and perks — to net income, representing the total economic benefit available to a single working owner-buyer. It is the right metric when the buyer plans to work in the business, as is common with SBA-financed individual acquisitions. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) adjusts owner compensation to a market-rate management salary rather than adding it back entirely, making it the correct metric when a buyer plans to hire a clinical director and manage the business as an investor. PE platforms universally use EBITDA. SBA buyers often use SDE for initial pricing, then convert to EBITDA for lender underwriting.
Yes. ABA therapy centers are eligible for SBA 7(a) financing, which is the most common structure for individual buyers acquiring practices in the $500,000–$5,000,000 price range. SBA 7(a) loans can finance up to 90% of the purchase price with a 10-year repayment term for goodwill-heavy transactions, requiring a 10% equity injection from the buyer. Sellers are often asked to carry a subordinated seller note — typically 5–15% of the purchase price — to fill the gap between the appraised value and the SBA loan amount. SBA lenders underwriting ABA practices will scrutinize BCBA staffing transferability, payor contract assignability, and billing compliance history as part of their credit analysis.
Expect buyers to conduct a detailed review across five areas: (1) payor mix analysis including reimbursement rates, contract terms, and renewal risk for all Medicaid and commercial contracts; (2) BCBA and RBT credentialing files, employment agreements, and non-compete enforceability; (3) billing compliance review covering 24–36 months of claims history, denial rates, and any prior audit correspondence; (4) clinical documentation sampling to verify treatment plan quality and session note completeness; and (5) client census analysis showing active caseload size, average authorization hours, attendance rates, and waitlist depth. PE buyers will also conduct quality of earnings (QoE) analysis and may engage a healthcare compliance consultant for billing diligence.
Earnouts are used in ABA therapy center deals when there is disagreement between buyer and seller on forward revenue assumptions — most commonly when the seller projects growth from a large waitlist or recently executed payor contracts that have not yet matured into full revenue. A typical earnout structure ties 10–20% of the total purchase price to achieving specific revenue or EBITDA targets over 12–24 months post-close. Sellers should negotiate for earnout metrics that are within their control during the transition period and ensure the buyer cannot artificially suppress earnings through expense allocation. Earnouts are more common in PE platform acquisitions than SBA-financed deals, where lenders prefer clean upfront valuations.
More Autism Therapy Center Guides
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers